Immunic Therapeutics

Immunic Therapeutics Immunic, Inc. (Nasdaq: IMUX) is a clinical-stage biopharmaceutical company with a pipeline of select

Thank you to everyone who connected with us at this year’s Annual Meeting. It was a great opportunity to engage with t...
06/03/2026

Thank you to everyone who connected with us at this year’s Annual Meeting. It was a great opportunity to engage with the ( ) community, exchange perspectives and discuss emerging research. 🤝

At our booth and during the poster sessions, we shared additional analyses from our phase 2 trial evaluating calcium in progressive MS ( ).

Highlights:
🧾 Our late-breaking poster introduced a novel unified endpoint for assessing confirmed disability changes in PMS trials

📊 Patient-reported outcome data from CALLIPER favored vidofludimus calcium over placebo

🛡️ Additional CALLIPER data supports the favorable and profile of vidofludimus calcium

Learn more about the data presented at CMSC: https://bit.ly/3Q77Pac

The Consortium of Multiple Sclerosis Centers

06/02/2026

🚶‍♀️ May 50K Challenge for MS – completed ✅

Over the course of May, colleagues across got active in their own way, all in support of people living with ( ). 🚴‍♂️🏊‍♀️ With everyone reaching their individual targets, Immunic doubled the initial donation.

A meaningful initiative that brought together movement, , and support for the MS community. Well done, team – to be continued. 💙

Deutsche Multiple Sklerose Gesellschaft, Bundesverband e.V. , MS Society UK , Stichting MS Research , Multiple Sclerosis International Federation , Multiple Sclerosis Ireland ,

✨ Marking Erik Lundgren’s first day as the new Chief Executive Officer of , featured on the tower in . 🏙️We look for...
06/01/2026

✨ Marking Erik Lundgren’s first day as the new Chief Executive Officer of , featured on the tower in . 🏙️

We look forward to this next phase of growth. Thank you, Nasdaq, for the continued support and welcome to , Erik.

🧠 On , the focus is on the many realities behind a diagnosis of (MS).This year’s theme 'My MS Diagnosis' highlights t...
05/30/2026

🧠 On , the focus is on the many realities behind a diagnosis of (MS).

This year’s theme 'My MS Diagnosis' highlights the diversity of experiences that shape how the disease is first understood and navigated. Listening to and learning from these individual perspectives remains essential to advancing our collective understanding of .

🎗️ At , we support this effort through our ongoing research, contributing to the broader goal of better understanding the disease.

We invite you to take a moment today to explore the stories shared as part of World MS Day. 🧡

World Multiple Sclerosis (MS) Day

🧠 The (MS) journey usually starts with a diagnosis, but no two look the same.Ahead of , this year’s theme 'My MS Diag...
05/29/2026

🧠 The (MS) journey usually starts with a diagnosis, but no two look the same.

Ahead of , this year’s theme 'My MS Diagnosis' shines a light on these individual starting points and what they mean for the path ahead.

At , we support this effort through ongoing research in , with a focus on deepening the understanding of the disease, its biology and and its drivers. 🎗️

World Multiple Sclerosis (MS) Day

🎗️ At 2026, will present additional phase 2 trial data in progressive ( ).🧾 Our late-breaking poster introduces ...
05/28/2026

🎗️ At 2026, will present additional phase 2 trial data in progressive ( ).

🧾 Our late-breaking poster introduces a novel unified endpoint, Confirmed Disability Change (CDC), designed to capture both confirmed disability worsening (CDW) and confirmed disability improvement (CDI) within a single statistical framework. When applying three complementary statistical approaches post-hoc to CALLIPER data, results consistently favored calcium over placebo.

📊 Additional CALLIPER data further highlight vidofludimus calcium’s favorable and profile, and patient-reported outcomes assessments showed no negative impact on mood.

Get all the details here: https://bit.ly/3Q77Pac

If you are attending CMSC, we welcome you to join today’s poster sessions or connect with our team at booth 307.

The Consortium of Multiple Sclerosis Centers

📢 At a pivotal moment in ’s evolution toward becoming a fully integrated, commercial-stage company, we are very pleas...
05/27/2026

📢 At a pivotal moment in ’s evolution toward becoming a fully integrated, commercial-stage company, we are very pleased to welcome Erik Lundgren as our new Chief Executive Officer, starting on June 1st.

Erik brings nearly two decades of proven biopharmaceutical experience, including deep expertise in ( ) and a strong track record in commercial strategy and product launches. Most recently, he served as Senior Vice President, Commercial Portfolio Organization at Genentech, overseeing the commercial strategy across all therapeutic areas of the company’s portfolio.
His experience will be instrumental as we advance calcium through late-stage clinical development in MS and prepare for potential regulatory approval and commercialization.

Erik succeeds Dr. Daniel Vitt, who will continue to support Immunic’s scientific strategy and remain a member of the Board of Directors.

As new , Erik will lead Immunic’s next phase of growth, working closely with our management and leadership teams and the Board of Directors.

👉 Learn more: https://bit.ly/4e76UzK

🧠 will be attending this year’s Consortium of Multiple Sclerosis Centers ( ) Annual Meeting in Charlotte, NC, USA, inc...
05/26/2026

🧠 will be attending this year’s Consortium of Multiple Sclerosis Centers ( ) Annual Meeting in Charlotte, NC, USA, including new data from our phase 2 trial in progressive MS ( ). We look forward to contributing to the scientific and medical dialogue and engaging with the community throughout the event. 💬

If you are attending CMSC, feel free to stop by and connect with our team at booth 307. 🤝

The Consortium of Multiple Sclerosis Centers

Address

1200 Avenue Of The Americas, Suite 200
New York, NY
NY10036

Telephone

+4989208047700

Website

Alerts

Be the first to know and let us send you an email when Immunic Therapeutics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category